Biogen is a global biotechnology company that leads innovative scientific research with the goal of defeating devastating neurological diseases. The company’s technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.

​

Ci's principals have worked with Biogen on numerous projects including a 18,000-square-foot lab and office renovation with equipment inventory and a relocation plan for an existing program, a 1,300-square-foot PET scan preclinical nuclear imaging facility, a 300-square-foot procedure room renovation, and a 500-square-foot necropsy lab renovation. 

​